photo
Speaker

John Craighead, PhD

CHIEF FINANCIAL OFFICER, ELPISCIENCE BIOPHARMACEUTICALS
Pudong, Shanghai, China
Dr. Craighead is an accomplished biotech veteran with over 15 years of experience leading equity financings, corporate partnerships, and strategic investor relations for biotech and pharmaceuticals companies. Prior to Elpiscience, he held leadership roles at GRAIL, Sanofi, Atara Biotherapeutics, and Human Genome Sciences.
Earlier in his career, Craighead was a biotechnology analyst at Lehman Brothers and managing director at BIO (Biotechnology Innovation Organization). He is a National Science Foundation Fellowship recipient and received his Ph.D. in Biological Sciences from Scripps Research, La Jolla, Calif.
Speaking In
10:45 AM - 12:00 PM (PDT)
Monday, June 13
Partnering activity in China continued to accelerate in 2021 with 658 deals generating a record $42…